March 22-24, 2021 | 10:00AM EDT | 2:00PM UTC | 3:00PM CET*
*Program is in development and subject to change
The frequency of nonalcoholic fatty liver disease (NAFLD) has risen worldwide in parallel with the obesity epidemic; however, there are still no approved therapies. The more advanced form of the disease, non-alcoholic steatohepatitis (NASH), is associated with progressive fibrosis and an increased risk of hepatocellular carcinoma (HCC). In the last decade, genetic studies have identified new proteins that participate not only in the development of hepatic steatosis, but also disease progression to NASH, cirrhosis, and HCC. Meanwhile, research is starting to emerge describing underlying molecular pathways that mediate alterations in lipid and glucose metabolism, which leads to fat accumulation in liver. Therefore, the goals of this conference are to: 1) Explore the genetic contributions to NAFLD, and how these insights might reveal the sequence of events that cause NASH and cirrhosis; 2) Clarify the key molecular events in NAFLD and NASH, focusing on pathways that might provide therapeutic opportunities; and 3) Highlight emerging therapies for NASH. This conference comes at an opportunistic time, when several clinical trials are scheduled to conclude, providing critical data to enable scientists to refine research strategies for the future.
Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD
Abstract Submission:
‣ For Short Talk Consideration: February 9, 2021
‣ For Poster Booth: March 8, 2021
ePoster / SciTalk Submission: March 11, 2021
Financial Aid Application: March 8, 2021
*Please note, abstract submission is required
in order to submit an ePoster and/or Scitalk
#VKSFattyLiver21
Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.
Find out more about financial aid opportunities here!
Showcase your work to global audiences on the eSymposia platform!
Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration
ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:
To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.
Speaking at this eSymposia
Noura S. Abul-Husn
Icahn School of Medicine at Mount Sinai , USA
Kendra K. Bence
Pfizer Inc. , USA
Morris J. Birnbaum
Pfizer Inc. , USA
Chuhan Chung
Gilead Sciences , USA
Eran Elinav
Weizmann Institute of Science, Israel
Hashem B. El-Serag
Baylor College of Medicine, USA
Henry N. Ginsberg
Columbia University College of Physicians and Surgeons, USA
Daniel A. Heller
Memorial Sloan Kettering Cancer Center, USA
Helen H. Hobbs
University of Texas Southwestern Medical Center, USA
Jay D. Horton
University of Texas Southwestern Medical Center, USA
Mitchell A. Lazar
Perelman School of Medicine, University of Pennsylvania, USA
Lei Ling
NGM Biopharmaceuticals, USA
Mark A. McNiven
Mayo Clinic, USA
Lopa Mishra
George Washington University, USA
Catherine Postic
INSERM, Institut Chochin, France
Elizabeth K. Speliotes
University of Michigan, USA
Greg Steinberg
McMaster University, Canada
Tobias C. Walther
Harvard School of Public Health, USA
Hannele Yki-Järvinen
University of Helsinki, Finland
Subscribe to receive updates to the program for this meeting.
This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.